Search result for 'alembic pharmaceuticals'

Alembic gets USFDA nod for Doxorubicin Injection

June 30, 2025 12:15

Alembic Pharmaceuticals receives USFDA approval for its generic Doxorubicin Hydrochloride Liposome Injection used to treat various cancers, including ovarian cancer, AIDS-related Kaposi's sarcoma,...

Alembic Pharma Gets USFDA Approval for Generic High Blood Pressure Drug

May 23, 2025 13:49

Alembic Pharmaceuticals has received USFDA approval for its generic version of amlodipine and atorvastatin tablets, used to treat high blood pressure. This approval marks the company's 223rd ANDA...

Alembic Gets USFDA Nod for Generic Heart Drug

May 2, 2025 14:53

Alembic Pharmaceuticals has received USFDA approval to market generic Ticagrelor Tablets, a medication for preventing heart attack and stroke. The drug is therapeutically equivalent to...

Alembic Pharma Gets USFDA Approval for Generic Anticonvulsant

April 17, 2025 13:12

Alembic Pharmaceuticals receives USFDA approval to market Carbamazepine tablets (200mg) in the US. The generic drug is therapeutically equivalent to Novartis' Tegretol Tablets.

Prozeal Green Energy Files for Rs 700 Cr IPO

March 31, 2025 19:06

Prozeal Green Energy, a renewable energy solutions provider, has filed draft papers with Sebi for an initial public offering (IPO) to raise Rs 700 crore. The IPO comprises a fresh issue of equity...

Allchem Lifescience Files IPO Papers: Aims to Raise Rs 190 Cr

March 16, 2025 10:45

Allchem Lifescience, an Indian API manufacturer, has filed IPO papers with Sebi to raise Rs 190 crore via a fresh issue and OFS. The company specializes in piperazine derivatives and caters to...

Alembic Gets USFDA Nod for Generic Antidepressant Tablets

January 15, 2025 15:53

Alembic Pharmaceuticals has received USFDA approval for its generic version of Brexpiprazole tablets, used to treat major depressive disorder. The approval covers strengths ranging from 0.25 mg to...

Alembic Gets USFDA Nod for Generic Anti-Epileptic Drug

December 20, 2024 16:30

Alembic Pharmaceuticals receives USFDA approval for generic Divalproex Sodium delayed-release capsules, a treatment for epilepsy. The drug is therapeutically equivalent to Depakote Sprinkle capsules.

Alembic Gets 5 USFDA Observations for Gujarat Plant

November 23, 2024 21:02

Alembic Pharmaceuticals received five observations from the USFDA after an inspection of its Gujarat-based manufacturing plant. The company will respond to the observations within the stipulated...

Alembic Pharma Gets USFDA Nod for Generic Hypertension Treatment

November 11, 2024 12:46

Alembic Pharmaceuticals receives USFDA approval for its generic Diltiazem Hydrochloride extended-release capsules, indicated for hypertension treatment. The approval covers various strengths of the...

Alembic Pharma Gets USFDA Nod for Generic Hypertension Treatment

October 21, 2024 13:33

Alembic Pharmaceuticals receives USFDA approval for its generic Diltiazem Hydrochloride extended-release capsules used to treat hypertension, offering a cost-effective alternative to the brand-name...

Alembic Pharma Gets USFDA Nod for Generic Schizophrenia Drug

September 27, 2024 15:48

Alembic Pharmaceuticals receives USFDA approval for its generic version of Paliperidone extended-release tablets, indicated for treating schizophrenia. The drug is therapeutically equivalent to...

Alembic Pharma Gets USFDA Nod for Generic Albendazole Tablets

September 5, 2024 17:27

Alembic Pharmaceuticals has received USFDA approval for its generic version of Albendazole Tablets, indicated for treating infections caused by worms like Taenia solium and Echinococcus granulosus.

Alembic Pharma Gets USFDA Nod for Scalp Psoriasis Drug

August 26, 2024 17:07

Alembic Pharmaceuticals has received USFDA approval to market a generic medication for treating moderate-to-severe scalp psoriasis. The drug, Betamethasone Valerate Foam, is therapeutically...

Alembic Gets USFDA Approval for Generic Deep Vein Thrombosis Medication

August 13, 2024 16:54

Alembic Pharmaceuticals receives USFDA approval for its generic Dabigatran Etexilate Capsules (110 mg) for deep vein thrombosis and pulmonary embolism prophylaxis.

Alembic Pharma Q1 Net Profit Up 12% to Rs 135 Cr - Business News

August 8, 2024 15:55

Alembic Pharmaceuticals reported a 12% increase in net profit to Rs 135 crore for Q1 FY24. Total income also rose to Rs 1,564 crore. Read more about the company's performance.

Akums Drugs Shares Debut at 7% Premium - IPO Success

August 6, 2024 10:45

Akums Drugs shares listed on BSE and NSE with a 7% premium over the issue price, drawing strong investor interest. The IPO was oversubscribed 63 times.

Alembic Pharma Gets USFDA Approval for Generic Cancer Drug

August 2, 2024 13:18

Alembic Pharmaceuticals receives USFDA approval to market generic Nelarabine Injection for cancer treatment, expanding its portfolio to 211 ANDA approvals.

Akums Drugs IPO Over-Subscribed 63 Times

August 1, 2024 19:45

Akums Drugs and Pharmaceuticals' IPO received 63.56 times subscription on the final day, with strong participation from institutional investors. The IPO was a combination of a fresh issue and an...

Akums Drugs IPO Oversubscribed 4.4 Times on Day 2

July 31, 2024 20:51

Akums Drugs and Pharmaceuticals IPO receives 4.43 times subscription on Day 2, with strong interest from retail and institutional investors. The issue closes on Thursday.

Akums Drugs IPO Fully Subscribed on Day 1: Details

July 30, 2024 19:49

Akums Drugs and Pharmaceuticals IPO was fully subscribed on Day 1, with retail investors showing strong interest. The issue will close on August 1. Learn more.

Akums Drugs Raises Rs 829 cr From Anchor Investors Ahead of IPO

July 29, 2024 22:13

Akums Drugs and Pharmaceuticals has raised Rs 829 crore from anchor investors ahead of its IPO, which will open for subscription on July 30. The IPO is a combination of a fresh issue and an offer...

Akums Drugs IPO Opens July 30: Rs 1,857 Cr Issue

July 25, 2024 10:48

Akums Drugs and Pharmaceuticals' IPO to raise Rs 1,857 crore opens on July 30. The price band is set at Rs 646-679 per share. Learn more about the IPO details.

Alembic Gets USFDA Nod for Generic Selexipag Injection

July 15, 2024 13:32

Alembic Pharmaceuticals receives tentative USFDA approval for its generic Selexipag injection, a treatment for pulmonary arterial hypertension. The company may be eligible for 180 days of generic...

Alembic Pharma Gets USFDA Nod for Generic Bromfenac Ophthalmic Solution

July 9, 2024 14:13

Alembic Pharmaceuticals receives USFDA approval for its generic Bromfenac ophthalmic solution, indicated for post-cataract surgery inflammation and pain treatment.

Alembic Pharma Gets USFDA Approval for Ivosidenib Tablets

July 4, 2024 15:00

Alembic Pharmaceuticals receives tentative USFDA approval for its generic Ivosidenib tablets, a treatment for certain types of cancer of bone marrow and bile duct. The drug is therapeutically...

Alembic Pharma gets USFDA nod for Dabigatran Etexilate capsules

June 18, 2024 16:02

Alembic Pharmaceuticals receives USFDA approval for generic Dabigatran Etexilate capsules 75 mg & 150 mg, used for stroke and blood clot prevention in adults with atrial fibrillation. The company...

Alembic Pharma Gets USFDA Approval for Hereditary Angioedema Injection

June 17, 2024 13:29

Alembic Pharmaceuticals receives USFDA approval for its generic Icatibant injection, a treatment for acute attacks of hereditary angioedema (HAE) in adults. This is the company's first peptide...

Alembic Pharma Gets USFDA Nod for Heart Failure Drug

May 30, 2024 16:20

Alembic Pharmaceuticals receives USFDA approval to market a generic medication for heart failure, a therapeutically equivalent version of Novartis's Entresto tablets.

Akums Drugs IPO: Rs 680 cr via Fresh Issue - Sebi Filing

February 11, 2024 16:18

Akums Drugs and Pharmaceuticals Ltd files draft IPO papers with Sebi, aiming to raise Rs 680 crore through fresh issue and an offer-for-sale (OFS).

Alembic Pharma Q3 Profit Up 48% to Rs 180 cr

February 5, 2024 18:30

Alembic Pharmaceuticals reported a 48% increase in its consolidated net profit to Rs 180 crore for the third quarter ended December 2023, driven by strong sales across domestic and export markets.

Company Name
Price
Volume

Jaiprakash Power Ven
22.41 ( -1.10)
87358273

Vodafone Idea L
7.30 ( 0.00)
45064804

PC Jeweller L
17.97 ( -4.01)
40811741

Alok Industries Ltd.
22.16 (+ 10.41)
39154912

RattanIndia Power
15.84 ( -0.50)
38484752

MORE NEWS

Maharashtra Govt Delays Rs 1015 Crore Crop Insurance Premium

Maharashtra's New Gig Worker Law

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2025	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Advertise with us

Search result for 'alembic pharmaceuticals'

Alembic Acquires Utility Therapeutics for $12 Million

Alembic gets USFDA nod for Doxorubicin Injection

Alembic Pharma Gets USFDA Approval for Generic High Blood Pressure Drug

Alembic Gets USFDA Nod for Generic Heart Drug

Alembic Pharma Gets USFDA Approval for Generic Anticonvulsant

Prozeal Green Energy Files for Rs 700 Cr IPO

Allchem Lifescience Files IPO Papers: Aims to Raise Rs 190 Cr

Alembic Gets USFDA Nod for Generic Antidepressant Tablets

Alembic Gets USFDA Nod for Generic Anti-Epileptic Drug

Alembic Gets 5 USFDA Observations for Gujarat Plant

Alembic Pharma Gets USFDA Nod for Generic Hypertension Treatment

Alembic Pharma Gets USFDA Nod for Generic Hypertension Treatment

Alembic Pharma Gets USFDA Nod for Generic Schizophrenia Drug

Alembic Pharma Gets USFDA Nod for Generic Albendazole Tablets

Alembic Pharma Gets USFDA Nod for Scalp Psoriasis Drug

Alembic Gets USFDA Approval for Generic Deep Vein Thrombosis Medication

Alembic Pharma Q1 Net Profit Up 12% to Rs 135 Cr - Business News

Akums Drugs Shares Debut at 7% Premium - IPO Success

Alembic Pharma Gets USFDA Approval for Generic Cancer Drug

Akums Drugs IPO Over-Subscribed 63 Times

Akums Drugs IPO Oversubscribed 4.4 Times on Day 2

Akums Drugs IPO Fully Subscribed on Day 1: Details

Akums Drugs Raises Rs 829 cr From Anchor Investors Ahead of IPO

Akums Drugs IPO Opens July 30: Rs 1,857 Cr Issue

Alembic Gets USFDA Nod for Generic Selexipag Injection

Alembic Pharma Gets USFDA Nod for Generic Bromfenac Ophthalmic Solution

Alembic Pharma Gets USFDA Approval for Ivosidenib Tablets

Alembic Pharma gets USFDA nod for Dabigatran Etexilate capsules

Alembic Pharma Gets USFDA Approval for Hereditary Angioedema Injection

Alembic Pharma Gets USFDA Nod for Heart Failure Drug

Akums Drugs IPO: Rs 680 cr via Fresh Issue - Sebi Filing

Alembic Pharma Q3 Profit Up 48% to Rs 180 cr

TODAY'S MOST TRADED COMPANIES

MORE NEWS

Moneywiz Live!

ALL MONEYWIZ PAGES